Halofuginone treatment reduces interleukin-17A and ameliorates features of chronic lung allograft dysfunction in a mouse orthotopic lung transplant model.
about
Models of Lung Transplant Research: a consensus statement from the National Heart, Lung, and Blood Institute workshop.IL-17A Blockade Attenuates Obliterative Bronchiolitis and IFN-γ Cellular Immune Response in Lung Allografts.Chronic lung allograft dysfunction phenotypes and treatment.Update on Chronic Lung Allograft Dysfunction.Pentraxin 3 deficiency enhances features of chronic rejection in a mouse orthotopic lung transplantation model.Amelioration of radiation-induced lung injury by halofuginone: An experimental study in Wistar-Albino rats.
P2860
Halofuginone treatment reduces interleukin-17A and ameliorates features of chronic lung allograft dysfunction in a mouse orthotopic lung transplant model.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Halofuginone treatment reduces ...... hotopic lung transplant model.
@en
Halofuginone treatment reduces ...... hotopic lung transplant model.
@nl
type
label
Halofuginone treatment reduces ...... hotopic lung transplant model.
@en
Halofuginone treatment reduces ...... hotopic lung transplant model.
@nl
prefLabel
Halofuginone treatment reduces ...... hotopic lung transplant model.
@en
Halofuginone treatment reduces ...... hotopic lung transplant model.
@nl
P2093
P50
P1476
Halofuginone treatment reduces ...... hotopic lung transplant model.
@en
P2093
David M Hwang
Hisashi Oishi
Malcolm R Whitman
Masaaki Sato
Shaf Keshavjee
Shin Hirayama
Tereza Martinu
Tomohito Saito
Tracy L Keller
Yasushi Matsuda
P304
P356
10.1016/J.HEALUN.2015.12.003
P577
2015-12-10T00:00:00Z